Literature DB >> 24399770

Tendering and value-based pricing: lessons from Italy on human papilloma virus vaccines.

Livio Garattini1, Katelijne Van de Vooren, Nick Freemantle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24399770      PMCID： PMC3883150          DOI： 10.1177/0141076813512122

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Pricing human papillomavirus vaccines: lessons from Italy.

Authors:  Livio Garattini; Katelijne van de Vooren; Alessandro Curto
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

Review 2.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Authors:  Sun-Young Kim; Sue J Goldie
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

3.  Value based pricing for NHS drugs: an opportunity not to be missed?

Authors:  Karl Claxton; Andrew Briggs; Martin J Buxton; Anthony J Culyer; Christopher McCabe; Simon Walker; Mark J Sculpher
Journal:  BMJ       Date:  2008-02-02

4.  Something rotten in the state of clinical and economic evaluations?

Authors:  N Freemantle; A Maynard
Journal:  Health Econ       Date:  1994 Mar-Apr       Impact factor: 3.046

Review 5.  Economic evaluation of human papilloma virus vaccination in the European Union: a critical review.

Authors:  Daniela Koleva; Paola De Compadri; Anna Padula; Livio Garattini
Journal:  Intern Emerg Med       Date:  2011-02-11       Impact factor: 3.397
  5 in total
  6 in total

1.  Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?

Authors:  Katelijne van de Vooren; Alessandro Curto; Livio Garattini
Journal:  Eur J Health Econ       Date:  2015-05

2.  Factors associated with the pricing of childhood vaccines in the U.S. public sector.

Authors:  Weiwei Chen; Mark Messonnier; Fangjun Zhou
Journal:  Health Econ       Date:  2017-06-29       Impact factor: 3.046

Review 3.  Drug tendering: drug supply and shortage implications for the uptake of biosimilars.

Authors:  George Dranitsaris; Ira Jacobs; Carol Kirchhoff; Robert Popovian; Lesley G Shane
Journal:  Clinicoecon Outcomes Res       Date:  2017-09-29

4.  Pricing of HPV vaccines in European tender-based settings.

Authors:  Venetia Qendri; Johannes A Bogaards; Johannes Berkhof
Journal:  Eur J Health Econ       Date:  2018-07-26

Review 5.  Vaccine Prices: A Systematic Review of Literature.

Authors:  Rabia Hussain; Nadeem Irfan Bukhari; Anees Ur Rehman; Mohamed Azmi Hassali; Zaheer-Ud-Din Babar
Journal:  Vaccines (Basel)       Date:  2020-10-29

Review 6.  Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV.

Authors:  Simona Di Mario; Vittorio Basevi; Pier Luigi Lopalco; Sara Balduzzi; Roberto D'Amico; Nicola Magrini
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.